Terms: = Thyroid cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Treatment
5 results:
1. Cortisol Deficiency in Lenvatinib treatment of thyroid cancer: An Underestimated Common Adverse Event.
Monti S; Presciuttini F; Deiana MG; Motta C; Mori F; Renzelli V; Stigliano A; Toscano V; Pugliese G; Poggi M
Thyroid; 2022 Jan; 32(1):46-53. PubMed ID: 34663079
[No Abstract] [Full Text] [Related]
2. Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy.
Colombo C; De Leo S; Di Stefano M; Vannucchi G; Persani L; Fugazzola L
J Clin Endocrinol Metab; 2019 Mar; 104(3):779-784. PubMed ID: 30383218
[TBL] [Abstract] [Full Text] [Related]
3. Photoacoustic Imaging as an Early Biomarker of Radio Therapeutic Efficacy in Head and Neck cancer.
Rich LJ; Miller A; Singh AK; Seshadri M
Theranostics; 2018; 8(8):2064-2078. PubMed ID: 29721063
[TBL] [Abstract] [Full Text] [Related]
4. Effect of levothyroxine suppression therapy on plasma thrombin activatable fibrinolysis inhibitor antigen levels in benign thyroid nodules.
Akinci B; Demir T; Comlekci A; Yener S; Ozcan MA; Karaoglu O; Yuksel F; Secil M; Yesil S
Med Princ Pract; 2011; 20(1):23-8. PubMed ID: 21160209
[TBL] [Abstract] [Full Text] [Related]
5. Levothyroxine (LT4) suppression treatment for benign thyroid nodules alters coagulation.
Demir T; Akinci B; Comlekci A; Karaoglu O; Ozcan MA; Yener S; Yuksel F; Secil M; Yesil S
Clin Endocrinol (Oxf); 2009 Sep; 71(3):446-50. PubMed ID: 19138314
[TBL] [Abstract] [Full Text] [Related]
